Opportunity Information: Apply for PAR 23 225

The HIV/AIDS Scholars Using Nonhuman Primate (NHP) Models Program is an NIH Mentored Research Scientist Development Award (K01) opportunity intended to help early-stage investigators build a strong, independent research career focused on HIV/AIDS translational science. It targets researchers who are within 10 years of completing a terminal professional degree (such as a PhD or MD) or finishing residency training, and it provides a structured, mentored pathway to develop the skills, publication record, and preliminary data needed to compete for major independent funding later on, such as an NIH R01. The award is designed to support an intensive period of career development, combining protected time, salary support, and research resources so recipients can focus deeply on a well-justified research plan and a formal training and mentoring strategy.

A defining feature of this program is its scientific scope: the research and mentorship must center on HIV/AIDS translational studies that use nonhuman primates as preclinical models. In practice, that means proposed projects should leverage NHP models in ways that clearly connect mechanistic or preclinical findings to human health and clinical relevance, rather than stopping at basic observations. NIH expects awardees to be guided by an experienced mentorship team with complementary expertise, specifically including both (1) deep knowledge of NHP HIV/AIDS model systems and their preclinical application and (2) demonstrated ability to translate findings toward clinical application in humans. The overall goal is that, after three years of mentored and well-supported research career development, awardees are positioned to transition into independent investigator roles and secure subsequent grant support.

The program aligns with the NIH Strategic Plan for HIV and HIV-Related Research for FY 2021-2025. Research framed under this K01 is expected to speak to major HIV priorities such as reducing HIV incidence, developing next-generation HIV therapies, advancing research toward an HIV cure, and addressing HIV-associated comorbidities, coinfections, and complications. While applicants have flexibility in the specific scientific questions they propose, the emphasis is on translational impact and on using NHP models in ways that directly strengthen the pipeline from preclinical discovery to interventions, strategies, or insights relevant to humans.

This particular announcement is the version of the K01 that does not allow the candidate to lead an independent clinical trial. Applicants cannot propose to serve as the lead investigator for an independent clinical trial, a clinical trial feasibility study, or an ancillary study to a clinical trial under this FOA. However, the FOA does allow candidates to gain clinical trial experience when the clinical trial is led by a mentor or co-mentor, which can be useful for building translational skills without taking on the responsibilities and review expectations associated with leading a trial. Applicants who intend to lead a clinical trial or lead an ancillary clinical trial are directed to apply under the companion FOA designed for that purpose.

Eligibility is broad at the organizational level and includes many types of domestic U.S. institutions and entities such as public and private institutions of higher education, nonprofits (with or without 501(c)(3) status), for-profit organizations (other than small businesses), small businesses, and a wide range of governmental bodies (state, county, city or township, special district), as well as independent school districts and public housing/Indian housing authorities. The announcement also explicitly highlights a range of mission-driven and capacity-building eligible organizations, including Historically Black Colleges and Universities (HBCUs), Hispanic-serving institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, and Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), along with tribal governments and tribal organizations, faith-based or community-based organizations, and U.S. territories or possessions. At the same time, there are clear restrictions related to foreign involvement: non-domestic (non-U.S.) entities and foreign institutions are not eligible to apply, non-domestic components of U.S. organizations are not eligible, and foreign components (as defined by NIH policy) are not allowed under this FOA.

Administratively, this opportunity is offered by the National Institutes of Health as a discretionary grant under Funding Opportunity Number PAR-23-225, associated with CFDA numbers 93.242, 93.351, and 93.855. The listing indicates an original closing date of 2025-09-07. The program is fundamentally a career development mechanism: the core deliverable NIH is looking for is not only high-quality NHP-based translational HIV/AIDS science, but also a clear, credible plan showing how three years of mentored training and research productivity will culminate in the applicant becoming an independent investigator who is ready to compete successfully for future NIH research project grants.

  • The National Institutes of Health in the health sector is offering a public funding opportunity titled "HIV/AIDS Scholars Using Nonhuman Primate (NHP) Models Program (K01 Independent Clinical Trial Not Allowed)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.242, 93.351, 93.855.
  • This funding opportunity was created on 2023-06-28.
  • Applicants must submit their applications by 2025-09-07. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
Apply for PAR 23 225

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Browse more business programs for HIV and AIDS support

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Health

Next opportunity: Request for Information (RFI) on Advancing Inclusive Development (ID) & Diversity, Equity, Inclusion, and Accessibility (DEIA) Practices Within Existing Activities and Structures at USAID/Ethiopia

Previous opportunity: Limited Competition: Cooperative Human Tissue Network (CHTN; UM1 Clinical Trial Not Allowed)

Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for PAR 23 225

 

Applicants also applied for:

Applicants who have applied for this opportunity (PAR 23 225) also looked into and applied for these:

Funding Opportunity
Early Stage Investigator HIV/AIDS Research Using Nonhuman Primate (NHP) Models (R21 Clinical Trial Not Allowed) Apply for PAR 23 215

Funding Number: PAR 23 215
Agency: National Institutes of Health
Category: Health
Funding Amount: $400,000
Research Supplements to Promote Diversity in Health-Related Research (Admin Supp Clinical Trial Not Allowed) Apply for PA 23 189

Funding Number: PA 23 189
Agency: National Institutes of Health
Category: Health
Funding Amount: $500,000
Advancing Development of Diagnostics for Congenital and Adult Acquired Syphilis (R21 Clinical Trial Not Allowed) Apply for RFA AI 23 039

Funding Number: RFA AI 23 039
Agency: National Institutes of Health
Category: Health
Funding Amount: $275,000
Schizophrenia and related disorders during mid- to late-life (R01 Clinical Trial Optional) Apply for PAR 24 023

Funding Number: PAR 24 023
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Precision HIV Health: Integrating Data and Implementation Science to Accelerate HIV Prevention and Treatment (R21/R33 Clinical Trial Not Allowed) Apply for RFA MH 24 100

Funding Number: RFA MH 24 100
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Youth Violence Prevention Interventions (R01 - Clinical Trial Required) Apply for RFA MD 24 002

Funding Number: RFA MD 24 002
Agency: National Institutes of Health
Category: Health
Funding Amount: $500,000
Schizophrenia and related disorders during mid- to late-life (R21 Clinical Trial Optional) Apply for PAR 24 026

Funding Number: PAR 24 026
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Data Analysis and Coordination Center for the PsychENCODE Consortium (U24 Clinical Trial Not Allowed) Apply for PAR 23 234

Funding Number: PAR 23 234
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Cellular and Molecular Biology of Complex Brain Disorders (R01 Clinical Trial Not Allowed) Apply for PAR 24 024

Funding Number: PAR 24 024
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Cellular and Molecular Biology of Complex Brain Disorders (R21 Clinical Trial Not Allowed) Apply for PAR 24 025

Funding Number: PAR 24 025
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
New Access Points Apply for HRSA 25 085

Funding Number: HRSA 25 085
Agency: Health Resources and Services Administration
Category: Health
Funding Amount: Case Dependent
Primary Care-Based Screening Tool and Intervention Development for the Detection and Prevention of Abuse and Neglect in Older and Vulnerable Adults With, or at Risk for, Mild Cognitive Impairment and AD/ADRD (R61/R33 Clinical Trial Required) Apply for RFA AG 24 048

Funding Number: RFA AG 24 048
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Preclinical Proof of Concept Studies for Rare Diseases (R21 Clinical Trial Not Allowed) Apply for RFA TR 23 016

Funding Number: RFA TR 23 016
Agency: National Institutes of Health
Category: Health
Funding Amount: $275,000
Development and Validation of Harmonized Methodologies to Measure NAD+ and Related Metabolites in Clinical Trials (U01 Clinical Trial Required) Apply for RFA AG 24 039

Funding Number: RFA AG 24 039
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Medical Student Education Program Apply for HRSA 24 074

Funding Number: HRSA 24 074
Agency: Health Resources and Services Administration
Category: Health
Funding Amount: Case Dependent
Nurse Education, Practice, Quality and Retention (NEPQR) - Workforce Expansion Program (WEP) Apply for HRSA 24 098

Funding Number: HRSA 24 098
Agency: Health Resources and Services Administration
Category: Health
Funding Amount: $1,000,000
Partnerships With Common Fund Data Ecosystem Resources (U24 Clinical Trial not Allowed) Apply for RFA RM 23 013

Funding Number: RFA RM 23 013
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Limited Competition: Centers of Biomedical Research Excellence (COBRE) (Phase 3) - Transitional Centers (P30 Clinical Trial Optional) Apply for PAR 23 216

Funding Number: PAR 23 216
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
PHS 2023-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed) Apply for PA 23 230

Funding Number: PA 23 230
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Single Source: Accelerating Medicines Partnership Schizophrenia (AMP SCZ): Clinical Trial Data Processing, Analysis, and Coordination Center (U24 Clinical Trial Not Allowed) Apply for RFA MH 24 151

Funding Number: RFA MH 24 151
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

Inside Our Applicants Portal

  • Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
  • Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
  • Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Access Applicants Portal

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Learn More

 

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "PAR 23 225", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.

 

Ask a Question: